Role of Endothelial Function in SCI CVD Risk

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorCraig Hospital

About this trial

Individuals with spinal cord injury have heart attacks and strokes more frequently, and much earlier in life. People with spinal cord injuries develop plaque in vessels much faster, and the reasons why are unclear. Doctors generally attributed the increased risk with weight gain and developing diabetes, but many studies have shown that even without these common factors, plaque in vessels is developing more often and faster. Endothelial cells are a single layer of cells that line all vessels in the body and plays an important role in vessel health. Damage to endothelial cells is known to lead to heart attacks and strokes. Past studies on endothelial cells of people with spinal cord injury have been unclear. The investigators have new data that these cells are unhealthy after spinal cord injury a measurement. This includes measuring endothelial health by directly altering its function using a catheter in the arm and measuring small particles in blood called endothelial microvesicles. If the project is successful, the investigators will learn important information on the health of endothelial cells after spinal cord injury. The investigators will also be able to use these markers of endothelial cell function to create treatments to improve vessel health and prevent heart attacks and strokes later in life in people with spinal cord injury.

Eligibility criteria

Qualifiers

Men and women of all races, ethnic backgrounds>18 years of age

Traumatic spinal cord injury (Sports, Assault, Transport, Fall, Other Traumatic Causes)

Time since injury (> 12 months)

Paraplegia Motor Complete Injury (neurological level of injury at T2 or below, ASIA Impairment Scale A or B

Disqualifiers

History of high blood pressure

History cardiovascular disease (coronary artery disease, congestive heart failure, myocardial infarction, cerebrovascular accident).

History high cholesterol

History of Diabetes Type I or Type II

Trial design

Treatments tested in this trial

  • Brachial intra-arterial infusion of vasoactive and antioxidant drugs (acetylcholine, nitroprusside, ascorbic acid)
  • venous occlusion plethysmography
  • Acetylcholine
  • Sodium Nitroprusside
  • Ascorbic acid
  • venous phlebotomy

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Craig Hospital

Lead sponsor

University of Colorado, Boulder

Collaborator